New combo therapy aims to boost breast cancer treatment before surgery
Disease control
Recruiting now
This study tests whether adding hormone therapy to standard chemotherapy and HER2-targeted therapy improves tumor response before surgery in people with HER2-positive breast cancer. About 30 adults with stage II to III disease will participate. The goal is to see if this combinat…
Phase: PHASE2 • Sponsor: Legacy Health System • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC